CompletedPhase 1/2

Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

Saudi Arabia100 participantsStarted 2022-02-01

Plain-language summary

To evaluate and compare the effect of immunoadsorption effect of A-V ECMO on course of sepsis weaning from inotropes, weaning from the ventilator, duration of ICU stays and effect on mortality rate in patients with septic shock and respiratory failure due to ARDS followed severe lung contusion.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Those who had an age between 18-65 years old * patients ventilated for more than 10 days * with conscious level more than 8/15 on Glasgow Coma Scale Exclusion Criteria: pediatric patients below 18 years of age

What they're measuring

number of patients weaned from ventilators

Timeframe: 2 weeks

number of patients disharged from ICU

Timeframe: 2 weeks

Trial details

NCT IDNCT04555798

SponsorMohamed Gaber Allam

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2022-02-01

View on ClinicalTrials.gov More Patients With Respiratory Failure and Shocked trials